• Mineralys Therapeutics granted inducement equity awards to two new non-executive employees, covering stock options for 29,760 shares plus restricted stock units for 22,320 shares.
• Stock options start vesting May 4, 2026, with 25% vesting on first anniversary, then 1/48 vesting monthly over four years, subject to continued service.
• Restricted stock units start vesting May 4, 2026, with 25% vesting on each anniversary over four years, subject to continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605051734PRIMZONEFULLFEED9713854) on May 05, 2026, and is solely responsible for the information contained therein.